Semaglutide 30 mg

About Semaglutide

Semaglutide is an acylated GLP-1 receptor agonist featuring amino acid substitutions (Aib8, Arg34) and a fatty acid side chain that binds serum albumin, conferring a prolonged half-life of roughly 165 hours. It serves as a benchmark compound in incretin mimetic research, insulin resistance, and neuro-metabolic investigations.

Pen technology & delivery format

Semaglutide is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, 3 mL dial-calibrated laboratory dispensing system engineered to eliminate reconstitution variability, aerosolization, and volumetric measurement errors in repeat-dose research designs. Each pen is pre-filled with ≥99% HPLC-authenticated research peptide solution, features a tactile dial-a-dose click mechanism, and is preserved under 2–8 °C cold-chain storage with a verifiable batch Certificate of Analysis.

Handling & research compliance

This pre-filled pen is intended strictly for in-vitro and laboratory research use by qualified scientific investigators. It is not an approved medicine, medical device, food, or supplement, and is not for human or veterinary use, ingestion, or injection. Store refrigerated at 2–8 °C, protect from direct light, and follow accepted laboratory safety procedures. Statements have not been evaluated by any regulatory authority (FDA, EMA).